Skip to main content
Atrás
Watch Compare

Cardiol Therapeutics Inc.

Calidad de datos: 17%
CRDL
NASDAQ Manufacturing Chemicals
$1.42
▲ $0.06 (4.04%)
Cap. Mercado: 151.33 M
6 months return
—
Momentum
Neutral

Quick Summary

Price History

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E — -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

4 analistas

Consenso de analistas: objetivo medio vs precio actual y calificación.

Buy
Actual
$1.42
+425.5%
Objetivo
$7.44
$4.92
$7.89
$9.05
Pronóstico
P/E Futuro -5.83
EPS Futuro -$0.24
Ingresos Est. 7.64 M

Estimaciones de Ganancias

Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.24
-$0.47 – -$0.04
7.64 M 3
FY2026 -$0.38
-$0.43 – -$0.33
0.0 3

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.11 -$0.07 +36.4%
Q32025 -$0.11 -$0.12 -14.3%
Q22025 -$0.13 -$0.10 +20.0%
Q12025 -$0.13 -$0.10 +23.1%

ETFs Holding This Stock

YOLO logo YOLO AdvisorShares Pure Cannabis ETF
4.73% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio N/A Forward P/E -5.83
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 19.80 Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 151.33 M Enterprise Value N/A
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A